Skip to main content
. 2022 Oct 18;50(10):03000605221129154. doi: 10.1177/03000605221129154

Figure 2.

Figure 2.

Microorganisms identified in patients with carbapenem-resistant Enterobacteriaceae (CRE) with or without concomitant SARS-CoV-2 (COVID-19) that were included in a retrospective case–control study that aimed to identify the strains of CRE and the risk factors associated with acquiring these infections. The colour version of this figure is available at: http://imr.sagepub.com.